Correction: Islet-autoantibodies in gestational diabetes and risk of progression to postpartum diabetes: a systematic review and meta-analysis - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: The Role of Islet Autoantibodies in Gestational Diabetes and Their Association with Postpartum Diabetes Risk: A Systematic Review and Meta-Analysis

  • By

  • Frontiers Production Office

  • August 24, 2026

Share

  • 1

    The article is a correction regarding islet autoantibodies in gestational diabetes and postpartum diabetes risk.

  • 2

    Errors in the figures and captions were identified and corrected in the published version.

  • 3

    Figure 1's caption lacked copyright citation and labels denoting significance levels.

  • 4

    Figures 2, 3, and 4 were misassigned, with images and captions incorrectly placed.

  • 5

    The original article has been updated to reflect these corrections.

Original Source(s)

Correction: Islet-autoantibodies in gestational diabetes and risk of progression to postpartum diabetes: a systematic review and meta-analysis

  • by Frontiers Production Office

  • August 24, 2026

Related Content

Translating Continuous Glucose Monitoring Alarms Into Clinical Practice—Beyond Efficacy

Correction: Tamsulosin-Induced Gynecomastia: Reversible Adverse Effect

  • August 18, 2026

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

“There is incredible uncertainty in drug dosing.”